Groowe Groowe / Newsroom / CBIO
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

CBIO News

Crescent Biopharma, Inc. Common Stock

Crescent Biopharma Announces Grants of Inducement Awards

globenewswire.com
CBIO

CineBlock Launches Entertainment Investment Marketplace, Opening Film and Media Ownership to Everyday Fans

accessnewswire.com
CBIO

Crescent Biopharma Announces Regulatory Clearances of IND Applications for CR-001, a PD-1 x VEGF Bispecific Antibody and CR-003, an ITGB6-targeted ADC, for the Treatment of Solid Tumors

globenewswire.com
CBIO

Crescent Biopharma Announces Grants of Inducement Awards

globenewswire.com
CBIO

Crescent Biopharma Announces Transformational Partnership with Kelun-Biotech and $185 Million Private Placement, Accelerating and Expanding Global Pipeline of Next Generation Therapeutics for Solid Tumors

globenewswire.com
CBIO

Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics

globenewswire.com
CBIO

Comanche Biopharma Appoints Richard Colvin, MD, PhD as Global Head of R&D and John McHutchison, AO, MD as Chairman and Director of Comanche Biopharma Australia

globenewswire.com
CBIO BBIO NVS TUNE VELI ASMB GILD

Crescent Biopharma Announces Grants of Inducement Awards

globenewswire.com
CBIO

Crescent Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights

globenewswire.com
CBIO

Crescent Biopharma to Present at November Investor Conferences

globenewswire.com
CBIO